NEW YORK – Analyzing circulating tumor DNA can both speed up and boost the enrollment of cancer patients into clinical trials, according to a new study focusing on gastrointestinal cancer.
NEW YORK – Analyzing circulating tumor DNA can both speed up and boost the enrollment of cancer patients into clinical trials, according to a new study focusing on gastrointestinal cancer.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.